Abstract
Abstract : Neurotoxic mechanisms and interactions between NMDA antagonists and acetylcholinesterase inhibitors (AChEIs)/cholingeric agonists were investigated using patch clamp recordings in rat brain slices of posterior cingulate/retrosplenial cortices (PCC/RSC), Functional Observational Battery monitoring, and Fluoro-Jade B (FJ-B) neurodegeneration staining. We obtained direct evidence that NMDA-mediated excitatory postsynaptic currents (EPSCs) in interneurons are blocked by NMDA antagonists (MK-801), the first direct evidence for their hypothesized neurotoxic mechanism. Physostigmine and pilocarpine suppressed GABAergic inhibitory postsynaptic currents; MK-801 was additive to them. In vivo, MK-801 is more neurotoxic in older than younger rats: in PCC/RSC slices, NMDA-mediated EPSCs were more rapidly suppressed by MK-801 in adults, suggesting a mechanism for age differences. Ethanol had more complex effects, and younger rats were more sensitive. In vivo, MK-801 alone produced FJ-B-positive neurodegeneration in the PCC/RSC, whereas, when used alone, AChEIs pyridostigmine and physostigmine did not. These findings are relevant to prevention of nerve agent exposures: NMDA antagonist drugs (e.g. for pain, neuroprotection, or recreation (e.g., ethanol)) could be co-administered with AChEIs (e.g., for soman prophylaxis). To avoid unexpected synergistic neurotoxicity in humans, the potential for serious neurotoxic interactions must be carefully explored in animals.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have